
CLOV Stock Forecast & Price Target
CLOV Analyst Ratings
Bulls say
Clover Health Investments is expected to have continued financial performance and profitability due to their high retention rate, demonstrated results of their software platform in improving health outcomes and lowering costs, and strong growth in markets with high adoption of the platform. Despite potential headwinds in 2027, including being paid as a 3.5-star plan and flat rates for Medicare Advantage plans, the company's focus on technology to improve care and contain costs makes them less dependent on rates for profitability. However, downside risks include regulatory changes, budget deficits, and competition in the Medicare Advantage market. There may also be volatility in medical costs, affecting earnings forecasts and investor confidence.
Bears say
Clover Health Investments is facing a challenging future as they try to maintain profitability while also absorbing new members and sustaining strong cohort economics. There are potential risks such as potential regulatory changes and the need for additional equity financing, which could negatively impact the company's ability to grow and remain profitable. Despite the potential for upside in certain scenarios, overall, the outlook for Clover Health Investments is negative due to these factors.
This aggregate rating is based on analysts' research of Clover Health Investments and is not a guaranteed prediction by Public.com or investment advice.
CLOV Analyst Forecast & Price Prediction
Start investing in CLOV
Order type
Buy in
Order amount
Est. shares
0 shares